(S1 (S (NP (NN LMP1)) (VP (VBZ Promotes) (NP (NN B) (NN Cell) (NP (NN Survival)) (CC and) (NP (NN Proliferation))) (ADVP (FW In) (FW Vitro)))))
(S1 (S (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (VP (VBZ MTS) (NP (NP (NN assay)) (PP (IN of) (NP (NP (NNS splenocytes)) (PP (IN from) (NP (NP (NP (NN WT)) (CC and) (NP (NN LMP1))) (JJ transgenic) (NNS mice)))))))) (. .)))
(S1 (S (S (NP (NNS Splenocytes)) (VP (VBD were) (VP (VBN cultured) (PP (IN in) (NP (NP (NP (NP (DT the) (NN presence)) (PRN (-LRB- -LRB-) (NP (NN grey) (NN bars)) (-RRB- -RRB-))) (CC or) (NP (NP (NN absence)) (PRN (-LRB- -LRB-) (NP (JJ black) (NN bars)) (-RRB- -RRB-)))) (PP (IN of) (NP (NN IL4))))) (PP (IN for) (NP (CD 3) (NN d)))))) (. .)))
(S1 (S (S (NP (DT The) (NNS results)) (VP (VBP are) (NP (NP (NP (DT the) (NN mean)) (CC +/-) (NP (NN SEM))) (PP (IN of) (NP (NP (JJ triplicate) (NNS samples)) (VP (VBN averaged) (PP (IN from) (NP (NP (JJ multiple) (NNS mice)) (SBAR (WRB where) (S (NP (`` ``) (NN n) ('' '') (S (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS mice)) (VP (VBN analyzed))))) (VP (VBZ is) (PP (IN as) (NP (VBZ follows)))))) (: :) (S (S (NP (NN n)) (VP (VBG =) (NP (CD 2)) (PP (IN for) (NP (NP (JJ WT) (NNS lymphocytes)) (CC and) (NP (JJ WT) (NNS lymphomas)))))) (, ,) (NP (NN n)) (VP (JJ =) (NP (NP (CD 11)) (PP (IN for) (NP (NN LMP1) (JJ transgenic) (NNS lymphocytes)))))) (, ,) (CC and) (S (NP (NN n)) (VP (JJ =) (NP (CD 13)) (PP (IN for) (NP (NN LMP1) (JJ transgenic) (NNS lymphomas))))))))))))))) (. .)))
(S1 (S (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NN EMA) (NN exclusion)) (PP (IN of) (NP (CD CD19+) (JJ gated) (NNS splenocytes))) (PP (IN from) (NP (NP (NP (NP (NN WT)) (CC and) (NP (NN LMP1))) (JJ transgenic) (NNS mice)) (VP (VBG showing) (NP (NP (NN percentage)) (PP (IN of) (NP (NP (JJ viable) (NN B) (NNS cells)) (VP (VBN cultured) (PP (PP (IN with) (S (PRN (-LRB- -LRB-) (NP (JJ white) (NNS bars)) (-RRB- -RRB-)))) (CC or) (PP (IN without) (NP (PRN (-LRB- -LRB-) (NP (JJ black) (NNS bars)) (-RRB- -RRB-)) (NP (NN IL4)) (PP (IN for) (NP (CD 2) (NN d))))))))))))) (. .))))
(S1 (S (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (NP (NN Flow) (NN cytometry) (NN analysis)) (PP (IN for) (NP (NP (VBN incorporated) (NN BrdU)) (PP (IN in) (NP (NP (NP (NN WT)) (CC and) (NP (NN LMP1))) (JJ transgenic) (NN lymphoma) (NNS cells)))))) (VP (VBN cultured) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (NN IL4)))) (PP (IN for) (NP (CD 2) (NN d))))) (. .)))
(S1 (S (S (NP (VBN Shown)) (VP (VBP are) (NP (NP (DT the) (NNS results)) (PP (IN from) (NP (NP (NN WT) (NN lymphoma) (CD 1)) (CC and) (NP (NN LMP1) (JJ transgenic) (NN lymphoma) (CD 2))))))) (. .)))
(S1 (S (S (NP (NP (NNS Percentages)) (PP (IN of) (NP (NNS cells))) (PP (IN in) (NP (DT each) (NN quadrant)))) (VP (VBP are) (VP (VBN shown)))) (. .)))
